{"id":4599,"date":"2026-08-17T12:57:27","date_gmt":"2026-08-17T12:57:27","guid":{"rendered":"https:\/\/www.inbody.in\/blog\/body-composition-analyzer-for-hospitals-india"},"modified":"2026-08-20T10:29:22","modified_gmt":"2026-08-20T10:29:22","slug":"body-composition-analyzer-for-hospitals-india","status":"publish","type":"post","link":"https:\/\/www.inbody.in\/blog\/body-composition-analyzer-for-hospitals-india","title":{"rendered":"Body Composition Analyzer for Hospitals: Clinical Spec Guide"},"content":{"rendered":"

Specifying a Body Composition Analyzer for a Hospital Is a Different Problem<\/h2>\n

A gym needs a fast test and a member-friendly printout. A hospital needs something else entirely: outputs that hold up in a clinical decision, fluid-status data that changes management, and a device that produces the same value on the same patient on Tuesday as it did on Monday.<\/p>\n

Buying a body composition analyzer for a hospital or clinic<\/strong> on gym specifications is the most common and most expensive procurement error in this category. This guide sets out what clinical settings actually require, which departments use which outputs, and what to put in the tender.<\/p>\n

\"InBody
InBody 770 clinical body composition analyzer used in Indian hospitals<\/figcaption><\/figure>\n

The Clinical Outputs That Justify the Specification<\/h2>\n

Three outputs separate a clinical-grade analyser from a professional fitness one. Each maps to a specific clinical use.<\/p>\n

Phase Angle<\/h3>\n

Phase Angle is derived from the ratio of reactance to resistance in the impedance measurement. It reflects cell membrane integrity and cellular health. Low values indicate cellular stress \u2014 seen in malnutrition, cancer cachexia and chronic disease \u2014 while higher values indicate robust cellular health.<\/p>\n

It is used clinically in oncology, nephrology and critical care to assess nutritional status and as a prognostic indicator. Only higher-end models measure it; the InBody 770S reports both whole-body and segmental Phase Angle. Our detailed explainer is at phase angle explained<\/a>.<\/p>\n

Extracellular to total body water ratio (ECW\/TBW)<\/h3>\n

The ratio of extracellular water to total body water is a direct fluid-balance indicator. It shifts with oedema, inflammation and fluid overload \u2014 which makes it directly relevant to dialysis management, cardiac failure, and post-surgical monitoring. Assessing it properly requires multiple frequencies, because separating intracellular from extracellular water is exactly what low and high frequency current does differently.<\/p>\n

Visceral fat area in cm\u00b2<\/h3>\n

A visceral fat level<\/em> is adequate for wellness contexts. A visceral fat area<\/em> in cm\u00b2 is a quantified value against a recognised clinical threshold \u2014 above 100 cm\u00b2 indicates elevated metabolic risk. For diabetology, endocrinology and metabolic clinics, the quantified area is the usable output.<\/p>\n

Which Departments Use What<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
Department<\/th>\nPrimary outputs used<\/th>\nTypical application<\/th>\n<\/tr>\n<\/thead>\n
Nephrology \/ dialysis<\/td>\nECW\/TBW, segmental water, Phase Angle<\/td>\nDry weight assessment, fluid overload monitoring<\/td>\n<\/tr>\n
Oncology<\/td>\nPhase Angle, skeletal muscle mass<\/td>\nCachexia detection, nutritional status, treatment tolerance<\/td>\n<\/tr>\n
Diabetology \/ endocrinology<\/td>\nVisceral fat area, SMM, body fat %<\/td>\nMetabolic risk stratification, therapy response<\/td>\n<\/tr>\n
Critical care<\/td>\nECW\/TBW, Phase Angle<\/td>\nFluid status, nutritional assessment<\/td>\n<\/tr>\n
Geriatrics<\/td>\nSegmental lean mass, SMM index<\/td>\nSarcopenia screening against AWGS criteria<\/td>\n<\/tr>\n
Bariatric \/ obesity clinic<\/td>\nBody fat mass, visceral fat area, SMM<\/td>\nPre- and post-operative composition tracking<\/td>\n<\/tr>\n
Sports medicine \/ rehab<\/td>\nSegmental lean analysis<\/td>\nPost-injury asymmetry, rehabilitation progress<\/td>\n<\/tr>\n
Paediatrics<\/td>\nGrowth-referenced composition<\/td>\nNutritional assessment in children from age 3<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Geriatrics deserves a specific note. Sarcopenia screening under the Asian Working Group for Sarcopenia criteria depends on appendicular skeletal muscle mass index, which requires reliable segmental limb measurement \u2014 not a whole-body figure. Our summary of the current criteria is at AWGS 2025 sarcopenia criteria for clinicians<\/a>.<\/p>\n

\"InBody
InBody 970 clinical-grade body composition analyzer close-up<\/figcaption><\/figure>\n

Why Frequency Count Is the Deciding Specification<\/h2>\n

For clinical work, the number of measurement frequencies is not a marketing tier. It determines which outputs are physically obtainable.<\/p>\n

    \n
  • Three frequencies<\/strong> (20, 50, 100 kHz \u2014 InBody 270S class) gives segmental muscle and fat, visceral fat level, and basic water compartments. Suitable for outpatient screening, wellness and general clinical use.<\/li>\n
  • Six frequencies<\/strong> (1 kHz to 1,000 kHz \u2014 InBody 770S) gives Phase Angle, segmental Phase Angle, segmental ECW\/TBW and visceral fat area in cm\u00b2. Required for nephrology, oncology, critical care and research.<\/li>\n<\/ul>\n

    Low-frequency current travels primarily through extracellular fluid; higher frequencies penetrate cell membranes into intracellular fluid. Without a wide frequency range, the intracellular and extracellular compartments cannot be cleanly separated \u2014 and every fluid-status output depends on that separation.<\/p>\n

    The InBody 970S extends this further with multi-frequency measurement up to 3 MHz and stores up to 100,000 measurements when patient IDs are entered, which matters for longitudinal departmental use.<\/p>\n

    Reproducibility: The Requirement Nobody Writes Into the Tender<\/h2>\n

    In a clinical setting, the question is rarely “what is this patient’s body fat percentage today”. It is “has this changed since last week, and does that change reflect the intervention”.<\/p>\n

    That makes reproducibility the governing requirement, and it depends on two things.<\/p>\n

    Fixed measurement start points.<\/strong> Tetrapolar 8-point tactile electrodes fix the measurement origin at the wrist and ankle every time. Without a fixed anatomical start point, small differences in hand or foot placement introduce variation that looks like clinical change.<\/p>\n

    No empirical estimation.<\/strong> If a device applies corrections based on age, sex or ethnicity, part of every result reflects population data rather than the patient. In a clinical context this is not a minor caveat \u2014 it means the device is partially reporting a demographic average back to you. InBody devices calculate directly from measured impedance per segment without these corrections.<\/p>\n

    \"InBody
    InBody 370S result sheet with segmental lean analysis and visceral fat<\/figcaption><\/figure>\n

    What to Put in the Specification Document<\/h2>\n
      \n
    1. Direct Segmental Multi-frequency BIA with independent measurement of all five body segments.<\/li>\n
    2. Tetrapolar 8-point tactile electrode system with fixed anatomical measurement start points.<\/li>\n
    3. Minimum six measurement frequencies where Phase Angle or fluid analysis is required; minimum three otherwise.<\/li>\n
    4. No empirical estimation based on age, sex or ethnicity \u2014 state this as a mandatory requirement, not a preference.<\/li>\n
    5. Phase Angle output, whole-body and segmental, where clinically indicated.<\/li>\n
    6. Segmental and whole-body ECW\/TBW ratio where fluid status is relevant.<\/li>\n
    7. Visceral fat area reported in cm\u00b2, not level alone.<\/li>\n
    8. Published validation against DEXA with study citation.<\/li>\n
    9. Patient-ID-based data storage with export capability and result-sheet printing suited to medical records.<\/li>\n
    10. Defined calibration schedule, service response time and authorised warranty support in India.<\/li>\n
    11. Test duration compatible with OPD throughput \u2014 around 60 seconds for the measurement itself.<\/li>\n
    12. Paediatric result sheet where the department tests children.<\/li>\n<\/ol>\n

      Installation and Practical Considerations<\/h2>\n

      A few points that surface after purchase rather than before:<\/p>\n

        \n
      • Siting.<\/strong> The device needs a level, stable floor and should not sit adjacent to sources of significant electrical interference.<\/li>\n
      • Protocol standardisation.<\/strong> Departments that get clean longitudinal data write a fixed testing protocol \u2014 time of day, position relative to dialysis or meals, hydration guidance \u2014 and enforce it. Departments that do not, generate noise.<\/li>\n
      • Staff training.<\/strong> The outputs are only as useful as the clinician’s familiarity with them. Phase Angle in particular is underused simply because staff have not been briefed on interpretation.<\/li>\n
      • Contraindications.<\/strong> As with any device passing a current through the body, follow the manufacturer’s guidance regarding patients with implanted electronic medical devices such as pacemakers.<\/li>\n<\/ul>\n

        InBody devices are in use across more than 1,500 Indian hospitals including AIIMS Delhi, PGI Chandigarh and Tata Memorial Mumbai, which makes peer reference checks straightforward during procurement.<\/p>\n